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Reactive oxygen species (ROS) are generated as the result of a number of physiological and pathological processes. Once formed ROS can
promote multiple forms of oxidative damage, including protein oxidation, and thereby influence the function of a diverse array of cellular
processes. This review summarizes the mechanisms by which ROS are generated in a variety of cell types, outlines the mechanisms which control
the levels of ROS, and describes specific proteins which are common targets of ROS. Additionally, this review outlines cellular processes which
can degrade or repair oxidized proteins, and ultimately describes the potential outcomes of protein oxidation on cellular homeostasis. In particular,
this review focuses on the relationship between elevations in protein oxidation and multiple aspects of cellular metabolism. Together, this review
describes a potential role for elevated levels of protein oxidation contributing to cellular dysfunction and oxidative stress via impacts on cellular
metabolism.
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Oxidative stress is correlated with a plethora of cellular
alterations including the accumulation of oxidized-damaged
molecules, increased levels of dysfunctional macromolecules,
and multiple compromises in cellular homeostasis. Oxidative
stress occurs when there are insufficient levels of antioxidants to
prevent reactive oxygen species (ROS) from promoting
deleterious levels of oxidative damage. Examples of ROS
include superoxide anion (O2
S−), hydroxyl radical (OHS),
singlet oxygen (1O2) and hydrogen peroxide (H2O2) [1]. Each
of these ROS is highly reactive and unstable due to the fact that
they contain an unpaired electron in their outer electron shell.
This conformation promotes their ability to rapidly interact with
cellular macromolecules such as proteins, lipids and nucleic
acids [1]. Thus, when cells are unable to sufficiently regulate the
levels of ROS, or are unable to adequately remove or replace
oxidized macromolecules, cellular dysfunction can occur via⁎ Corresponding author. Tel.: +1 859 257 1412x333; fax: +1 859 323 2866.
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cells to undergo oxidative stress appears to be cell type specific,
with cells exhibiting dramatic differences with regards to their
sensitivity to accumulate oxidized molecules and undergo
toxicity during periods of high ROS exposure. The basis for this
cell type specificity is poorly understood but is clearly an
important topic for aging, hepatic, cardiovascular, cancer, and
neuroscience research [2–4].
As mentioned previously there are several mechanisms by
which ROS may be generated including aerobic respiration,
nitric oxide synthesis, and NADPH oxidase pathways during
inflammation. In aerobic respiration, the mitochondrial respi-
ratory chain produces ROS as it transfers electrons during the
reduction of molecular oxygen to water. During this process
some electrons escape the electron transport chain and interact
with oxygen to generate O2
S−, OHS, or H2O2 [5]. The nitric
oxide synthase (NOS) enzymes produce nitric oxide (NO) via
the deamination of L-arginine to L-citrulline. NO is not highly
reactive per se but can interact with other intermediates like
oxygen, O2
S− and transition metal generating products that
affect the functionality of macromolecules. For example, the
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S− forms peroxynitrite (ONOO−), a
very reactive species that can cause several alterations
especially the inactivation of proteins [6]. Finally, inflammatory
cells can utilize the NADPH oxidase complex to generate
several oxygen radicals including O2
S− and H2O2 in order to kill
bacteria and other fungal pathogens. Activated neutrophils can
also release the enzyme myeloperoxidase which produces the
highly active oxidant hypochlorous acid (HOCl) from hydrogen
peroxide and chloride ions.
In addition to these biological mechanisms of ROS
generation there are also exogenous sources of free radicals
including drugs, man-made pollutants like ozone, environmen-
tal toxins like rotenone and 3-nitropropionic acid (3-NP),
cigarette smoke, radiation, and various fungal and bacteria
toxins such as ochratoxin A and aflatoxin B1 [6–8]. Ozone (O3)
is one of the major oxidants present in air and is the cause of
several pathologies for epithelial cells and the respiratory tract
[9]. At physiological pH ozone reacts with water, producing free
radicals like OH
S
which can promote the oxidation of amino
acids and lipids. DNA can also be altered by ozone to cause the
formation of 8-oxodeoxyguanosine [10]. Ozone has also been
shown to inactivate antioxidant enzymes such as superoxide
dismutase, catalase and glutathione peroxidase. Such effects
further disrupt the balance between oxidation and antioxidant
pathways [11], and thereby promotes oxidative stress.
The environmental pollutants rotenone and 3-NP are
established inhibitors of mitochondria function and have been
demonstrated to be pro-apoptotic. Rotenone is a lipophylic
compound often used as a component of insecticides, or
maintenance of fish populations, and generates ROS through
the inhibition of mitochondrial complex I leading to an increase
in H2O2 [12]. Interestingly, rotenone has been identified to
cause some forms of Parkinsonism [13]. Similarly 3-NP has
toxic effects towards the brain, causing symptoms similar to
those in Huntington disease (HD) [14]. Much like rotenone, 3-
NP generates ROS through the inhibition of the mitochondria
enzyme, succinate dehydrogenase [15,16]. These studies
provide experimental support for impairments in metabolism
(mitochondria), serving as a promoter of oxidative stress.
Cigarette smoke is linked to several human diseases
including bronchitis, emphysema, vascular disease, and a
large number of cancers [17]. Cigarette tar is the major
component responsible for the carcinogenic activity of cigarette
smoke. It consists of quinone and hydroquinone molecules that
promote a very reactive deleterious redox system involving
O2
S−, OHS, NO and H2O2 [18–21]. These species cooperatively
promote DNA damage, protein oxidation, and lipid peroxida-
tion. Cigarette smoke is also capable of converting tyrosine to 3-
nitrotyrosine and dityrosine, promoting further protein
oxidation.
Ionizing radiations, like X- and λ-rays, also have important
roles in the production of free radicals. Radiation-induced ROS
generation requires the presence of oxygen and water. The
highest reactive species formed from ionizing radiation is the
hydroxyl radical, which is formed from the radiolysis of water
[22]. Once formed, these reactive species can rapidly cause
DNA and protein damage. Germ cells in the gonads, bonemarrow cells and embryonic stem cells are extremely sensitive
to the action of radiation because of their active and continuous
proliferation. Proteins high in cysteine and methionine residues,
such as crystallin, are particularly vulnerable to X-ray oxidation.
Oxidation of these proteins may result in the unfolding of the
proteins and formation of disulfide-linked dimers and oligomers
[23]. Radiation may also cause oxidation of specific amino acid
residues in the active site of enzymes, thus reducing their
activity. For example, creatine kinase activity is greatly reduced
following X-ray exposure, possibly due to the oxidation of an
essential active site tryptophan [24].
Ultraviolet radiation (UVA or UVB) is a potent means of
producing ROS and also decreases the levels of antioxidants
enzymes [25]. The energy produced by UV-radiation is
transferred to molecular oxygen from endogenous chromo-
phores, like riboflavin, NADH−/NADPH and tryptophan. This
process leads to the production of O2
− which is rapidly converted
to H2O2. The final product is the highly reactive free radicalS
OH. The main consequences of these ROS appears to be
alterations to DNA strands, and the generation of 8-hydro-
xydeoxyguanosine (8-OHdG) [26,27]. Furthermore, these
species can interfere with the metabolism of collagen, down
regulating collagen synthesis and contribute to potentially
deleterious collagen oxidation and degradation [28]. UVA
protein oxidation may also lead to the stabilization of various
cell cycle proteins, such as p53, and cause an increase in the
amount of pro-apoptotic proteins, such as FAS [29,30].
Additionally, UV may alter the activity of other proteins such
as transcription factors which could lead to deleterious
alterations in gene expression and cytotoxicity [31].
The toxic action of different fungal and bacteria metabolites
is often mediated by oxidative stress. It has been shown that
fungal toxins like ochratoxin A and aflatoxin B1, noted for their
carcinogenic effects, can lead to the formation of ROS. Indeed,
treatment of HepG2 and CaCo-2 cell lines with these two toxins
induces a dose-dependent increase in ROS generation including
O2
− and
S
OH [32]. Similar effects have been observed in
different animal models. Rat hepatocytes and proximal tubular
cells treated with these same toxins show an increase in the
levels of ROS [33,34]. Although the majority of studies with
these two compounds have focused on their ability to induce
lipid peroxidation, more recent reports have shown that both
ochratoxin A and aflatoxin B1 are capable of oxidizing proteins.
For example, ochratoxin A was shown to induce protein
carbonyls in a dose-dependent manner in rats [35]. Additionally,
aflatoxin B1 was shown to oxidize the lysine residues of
proteins [36].
2. Antioxidants
To protect organelles and cellular components against ROS-
associated damage cells have developed several antioxidant
defense systems. These can be divided into enzymatic and non-
enzymatic mechanisms of ROS detoxification. The non-
enzymatic antioxidants include lipid-soluble compounds like
vitamin E (α-tocopherol) and vitamin A, and water-soluble
compounds like vitamin C (ascorbic acid), ceruloplasmin, uric
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major lipid-soluble anti-oxidant compound due to its unique
localization to cell membranes. In contrast, GSH is the major
water-soluble compound which is crucial for the maintenance
of enzymes and other cellular components in a reduced state
[37].
Additional enzymes and proteins can also act as antioxidants
including superoxide dismutase (SOD), catalase (CAT) and
glutathione peroxidase (GSH-Px). SOD is responsible for the
reaction that reduces the radical superoxide to form hydrogen
peroxide and oxygen (Fig. 1A). The SOD family includes three
different enzymes: cytosolic Cu/Zn-SOD (SOD-1), mitochon-
drial Mn-SOD (SOD-2) and extracellular SOD (SOD-3)
[38,39]. SOD-1 consists of two identical subunits and an active
site containing copper and zinc atoms linked by a histidine
residue. SOD-1 is constitutively expressed by all mammalian
cells and is localized in the cell cytosol and nucleus [40].
Interestingly, several stressors such as ozone, radiation, drugs,
NO and H2O2 can induce an increase in SOD-1 mRNA
expression. SOD-2 is a homotetramer with each subunit
containing a manganese atom. It is present in the inner
mitochondrial space, and like SOD-1 is expressed by different
cell types and tissues. Particularly high levels of SOD2 are
found in organs with high respiration rates such as the kidney,
liver and myocardium [41]. It has been shown that the activity
of SOD2 is correlated with cell proliferation. SOD-3 is a
tetrameric glycoprotein containing both copper and zinc [42].
The expression of SOD-3, unlike SOD-1 and SOD-2, is cell and
tissue specific. High levels of SOD-3 are present in alveolar
type II cells, proximal renal tubular cells, lung macrophages,
vascular smooth muscle cells, some fibroblast lines, glial cells,
and endothelial cells [42]. SOD-3 is able to detoxify superoxide
specifically in the extracellular spaces and fluids, such as
plasma and lymph. The final product of the activity of each of
the aforementioned SOD types is the production of is H2O2.
H2O2 is extremely dangerous for cells and is therefore
immediately removed by two enzymes: catalase (CAT) and
glutathione peroxidase (GSH-Px).
CAT is present in the peroxisomes and leads to the
neutralization of H2O2 resulting in the formation of water and
molecular oxygen (Fig. 1B). It is particularly active in liver,
lung and kidney, and erythrocytes in humans [43]. Like other
antioxidants enzymes, catalase activity is altered following
exposure to oxidative stressors like UV-radiation [44], cigarette
smoke [45] and ozone [46].Fig. 1. Anti-oxidation reactions catalyzed by specific cellular antioxidant
enzymes. Superoxide dismutase reduces the superoxide radical in order to form
hydrogen peroxide and oxygen (A) which can then undergo further
detoxification. Catalase neutralizes reactive hydrogen peroxide by forming
non-toxic water and molecular oxygen (B). Glutathione peroxidase also aids in
the clearance of hydrogen peroxide by catalyzing the production of water and
GSSG from hydrogen peroxide (C).GSH-Px is an antioxidant enzyme which, in contrast to CAT,
works in the cytosol and mitochondria. GSH-Px removes
hydrogen peroxide by oxidizing reduced glutathione to
oxidized glutathione (GSSG) (Fig. 1C). The GSH-Px family
consists of four selenoproteins characterized by differences in
localization and molecular structure [47]. The first enzyme to be
identified was the cytosolic glutathione peroxidase (cGPx)
which is ubiquitously expressed. cGPx is a tetramer of cGPx
and each subunit contains a selenocysteine residue that is
essential for all catalytic activity. cGPx is able to only react with
soluble hydroperoxides like H2O2. Indeed, without the presence
of phospholipase A2 activity, that releases fatty acids, cGPx
cannot metabolize fatty acid hydroperoxides present in
phospholipids. The second form of GSH-Px is the plasma
glutathione peroxidase (pGPx). Studies in rats have revealed
that the majority of pGPx is generated in the kidney, although
expression has also been shown in the liver, lung, heart, breast
and placenta [48]. Once formed, pGPx is secreted into the
extracellular space and can be found not only in the plasma but
also in the lung lavage, breast milk and amniotic fluid. Lung
cells, like epithelial cells and macrophages, can produce and
secrete the pGPx into epithelial lining fluid [49]. This property
makes the enzyme of particular interest as a defense against
exposure to exogenous oxidants such as cigarette smoke and
ozone. The third type of GSH-Px is the gastrointestinal
glutathione peroxidase (GI-GPx) which has been detected in
human liver and colon [50]. This highly selective distribution
suggests that the main function of this enzyme subtype is to
detoxify ingested lipid hydroperoxides and H2O2 formed as a
consequence of liver effects on alimentary xenobiotics [50].
Lastly, GSH-Px is a phospholipid hydroperoxide glutathione
peroxidase (PH-GPx). Testis presents the highest activity of this
enzyme, suggesting it plays a role in sexual maturation and
differentiation [47]. The main characteristic of this enzyme is its
ability to detoxify a wide range of lipid hydroperoxides,
including phosphatidylcholine hydroperoxide and those derived
from cholesterol. Unlike the other forms of GSH-Px, PH-GPx is
a monomer and this small size helps it to interact with
hydroperoxides integrated in membranes [47]. Indeed, PH-GPx
has been studied for its ability to confer protection against the
UV irradiation and ROS-mediated peroxidation of phospholi-
pids in cellular membranes, thereby preventing cellular damage
and tissue breakdown [51].
Under normal conditions cells succeed in limiting the
amount of damage from ROS attack thanks to the activity of
these various antioxidant defense mechanisms. Unfortunately if
cells undergo extremely high levels of oxidative stress, or if
reduction of antioxidant activities occurs, macromolecules may
become damaged and lead to loss in cellular function and
oxidative stress. Oxidation of DNA can cause single and double
strand breaks and alter DNA–protein and DNA–DNA interac-
tions. Additionally, oxidation of proteins may cause changes in
amino acids structure, increases in protein hydrophobicity and a
loss of enzymatic activity. Oxidized proteins are normally
recognized and degraded by intracellular proteases, such as the
proteasome complex. Unfortunately, there is accumulating
evidence that free radicals can react with these proteolytic
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proteins are not efficiently removed, oxidized proteins may
accumulate and alter cell function and promote toxicity [52,53].
3. Protein oxidation
While there are many types of oxidative damage, increasing
evidence suggest an important role for protein oxidation in
aging and multiple diseases [37,54–56]. The importance of
protein oxidation towards cellular homeostasis derives from the
fact that proteins serve vital roles in regulating cell structure,
cell signaling, and the various enzymatic processes of the cell.
Protein oxidation can therefore rapidly contribute to oxidative
stress by directly affecting cell signaling, cell structure, and
enzymatic processes such as metabolism. There are many
different modes of inducing protein oxidation including metal
catalyzed oxidation, oxidation induced cleavage, amino acid
oxidation, and the conjugation of lipid peroxidation products.
There is evidence that the metal-catalyzed oxidation (MCO)
of proteins is one the most common mechanisms for inducing
protein oxidation, especially for the introduction of carbonyl
groups. This process requires the generation of H2O2 and the
presence of ions such as Fe (III) or Cu (II). NADH and NADPH
oxidase and other oxidation systems catalyze the formation of
H2O2 and Fe (II) or Cu (I). This derives from oxygen and from
Fe (III) or Cu (II) [56–58]. Fe (II) and Cu (I) ions then bind to a
specific metal binding site within the protein and react with
H2O2 to generate
S
OH that then attacks the amino acid residues
near the metal binding site [56–58].
ROS can also induce the cleavage of peptide bonds in
proteins via two separate pathways: the diamide pathway and α-
amidation pathway [58]. Hydroxyl radical, generated from
radiolysis of water or generated from H2O2, reacts with proteins
to form water and a carbon-centered radical (alkyl-radical). This
radical can then cross-link with other alkyl-radicals and form
protein aggregates or react with O2 to generate an alkyl-
peroxide radical. This can then be converted, through the action
of Fe (II) or HO2
S
, to alkyl peroxide [56,58]. Alkyl peroxide can
then react with Fe (II), HO2
S
or by a dismutation reaction, to
produce an alkoxyl radical [56,58]. The cleavage of the peptide
bond can also be obtained by the reaction of the free radicalS
OH with the glutamyl, prolyl and aspartyl residues of the
protein chain [58,59].
Several amino acids can be directly modified via side chain
reactions with ROS. The most sensitive amino acids are those
with aromatic side chain groups and those containing sulfhydryl
groups. In terms of aromatic side-chain amino acids, ROS-
induced oxidation can occur through a variety of intermediates.
For example, the oxidation of phenylalanine residues leads to
the formation of mono- and di-hydroxy derivatives whereas
tryptophan residues are converted to several hydroxy-deriva-
tives, to formylkynurenine and to nitrotryptophan [56–58].
Furthermore, histidine residues can be oxidized to 2-oxohisti-
dine and 4-OH-glutamate, while tyrosine residues are converted
to a dihydroxy-derivative (dopa), nitrotyrosine, chlorotyrosine
and a dityrosine derivative [56–58]. Interesting, in the case of
nitrotryosine, the interaction between the two tyrosine radicalscan be intra- or inter-molecular, promoting the production of
potentially harmful protein aggregates [56–58]. Furthermore,
the presence of the dityrosine derivatives can be used as a
marker to determine the amount of cellular oxidative damage
induced by free radicals [56].
In contrast to aromatic amino acids, methionine and
cysteine resides are oxidized via reactions at the site of
sulfhydryl residues. Both cysteine and methionine residues can
interact with ROS resulting in the production of sulfoxide,
sulfenic acids, and disulfide bridges [56,57,60]. Cysteine is
also vulnerable to oxidant induced cross-linking. Oxidative
modifications of sulfur-containing amino-acids can be revers-
ible. For example, in the cytosol and the mitochondria of
eukaryotic cells there are the thioredoxin and glutaredoxin
systems which are responsible for the reduction of cysteine
residues [61]. Once thioredoxin and glutaredoxin are oxidized,
they can then be reduced via the actions of thioredoxin
reductase and a glutathione reductase, respectively, in an
NADPH dependent manner. A similar mechanism of reduction,
called the methionine sulfoxide reductase system, has been
demonstrated for the amino acid methionine. This system
consists of two major proteins, MsrA and MsrB, which can
reduce S-MetO and R-MetO, respectively. MsrA is the product
of single gene and it is present both in the cytosol and the
mitochondria. MsrA protein is highly expressed in human
liver, kidney, and brain [62]. In contrast, there are three
different MrsB enzymes, encoded by three genes, with
different localizations in cellular compartments. MsrB1 is a
selenoprotein and is present in the cytosol and in the nucleus.
MsrB2 is associated with the mitochondria while MsrB3,
which through alternative splicing originates two different
mRNAs, has been found both in the mitochondria and in the
endoplasmic reticulum. The highest levels of MsrB are in the
human bladder, heart and skeletal muscle, while the brain, liver
and kidney present low levels of the enzyme [62].
It has been demonstrated that both the enzymes, especially
the MsrA form, have a protective role toward protein oxidation
and premature death. Indeed, the overexpression of MsrA in
yeast, human T-cells [63], human lens epithelial cells [64] and
Drosophila [65] induces resistance to oxidative stress and
increases cell survival. Additional experiments utilizing mice
that lack the MsrA gene show an enhanced sensitivity to
hyperoxia and have reduced life span compared to wild type
controls [66]. Finally, senescent cells show a decrease in the
activity of these enzymes suggesting it may be the basis for the
accumulation of oxidized proteins observed during normal
aging [67].
The major product of protein oxidation, such as peptide bond
cleavage and amino acid oxidation, is the production of a
protein carbonyl. Carbonyl groups can be formed by secondary
reactions with the lipid peroxidation product 4-hydroxynonenal
(HNE), or with reducing sugars or their oxidation products
[6,56,57]. One of the most relevant consequences of the
presence of carbonyls is that they can further react with the α-
amino groups of lysine residues. This reaction leads to the
formation of intra- or inter-molecular cross-links which can
promote the formation of protein aggregates. These aggregates
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mechanisms, leading to the inhibition of proteolytic processes.
This lack of degradation can further induce the accumulation of
oxidized proteins and enhances cellular dysfunction [57].
Studies conducted on housefly and D. melanogaster show
that during normal aging or after exposure to hyperoxia there is
an increase in the amount of carbonyl groups on aconitase, an
important enzyme for mitochondrial metabolism. This increase
in carbonyl groups was correlated with a loss in enzymatic
activity [69,70]. Because of its central role in the citric acid
cycle, a decrease in aconitase activity can lead to an increase in
cellular oxidative status. In similar experiments the mitochon-
drial enzyme, adenine nucleotide translocase, was also showed
particular susceptibility to oxidation [71]. Furthermore, mam-
malian models show a selective age-related increase in
carbonyls levels in plasma proteins, particularly as part of
albumin, transferrin, and α1-macroglubulin [72]. Unfortunately,
the majority of oxidized proteins cannot be repaired and are
eliminated through various degradation processes, including
both proteasome-dependent and proteasome-independent path-
ways. This promotes their accumulation and ability to
contribute to cellular dysfunction.
4. Degradation of oxidized proteins
One of the most important processes for maintaining
homeostasis is the ability of proteolytic systems to eliminate
oxidized and damaged proteins. Cells degrade oxidized proteins
via the proteasome pathway and the lysosomal pathway. The
proteasome is considered the major pathway responsible for the
degradation and elimination of “mildly” oxidized proteins
[53,56–73] and is involved in regulating proteins involved in
several cellular activities like cell cycle. It is a multicatalytic
protease located in both the cytosol and the nucleus of
eukaryotic cells [74–76]. The catalytic core of the proteasome,
known as the 20S proteasome, is a cylinder-shaped structure
with a molecular weight of ∼700 kDa [74–76]. It is made of
four rings, each containing seven subunits. The two outer rings
are constituted of α-subunits while the inner ones of β-subunits.
In the constitutive proteasome the α-subunits are responsible
for regulating the function and stability of the proteasome
complex. In contrast, the β-subunits, which are characterized by
an N-terminal threonine residue, mediate all the catalytic
activity of the proteasome [74–76].
There are three main catalytic activities of the proteasome
which exhibit different substrate specificity. The chymotrypsin-
like activity (CT-like) cleaves substrates after hydrophobic
residues whereas the trypsin-like activity (T-like), cleaves the
substrate after basic residues. Finally, the peptidylglutamyl-
peptide hydrolase activity (PGPH) is responsible for cleaving
proteins after acidic residues [76]. In addition, two other
activities have been found in the proteasome: the BrAAP
activity (which cleaves the substrate after branched-chain amino
acids) and the SNAAP (which cleaves the substrate after small
neutral amino acids) [77].
In addition to the normal activities of the α and β subunits,
different proteins may bind the proteasome and regulate itsfunctions. The best characterized among them are the 19S cap
(or PA700) and the 11S cap (or PA28) [74]. The 19S cap
consists of 20 subunits and is able to bind to the external rings.
Upon binding, the newly formed structure is named the 26S
proteasome and requires ATP for its proteolytic activity. The
formation of the 26S proteasome promotes degradation of
ubiquitinated proteins as the 19S cap has a central role in
unfolding target proteins and in the recognition of the ubiquitin
chain [74]. The role of 20S versus 26S in degrading oxidized
proteins remains to be fully established, although it appears the
20S proteasome is responsible for most oxidized protein
degradation.
Ubiquitin is a small protein of 76 amino acids which can be
attached to damaged proteins in order to target them for
degradation. The ATP-dependent attachment of ubiquitin to
proteins is called polyubiquitination and involves three different
enzymes named E1, E2, and E3. E1 activates ubiquitin and
transfers it to E2, a ubiquitin-conjugating enzyme. Then E3
interacts with both E2 and the target protein, facilitating the
transfer of ubiquitin from E2 to the target protein. The reaction
is repeated several times in order to label the protein with an
ubiquitin chain which allows the target protein to be recognized
by the proteasome. Once the target protein is degraded, the
ubiquitin chain can then be disassembled via an isopeptidase
activity inherent in the 19S cap. This allows ubiquitin to be
effectively recycled [74]. It appears that ubiquitin plays a
minimal role in targeting oxidized proteins for degradation,
although it has been reported that oxidant-induced increases in
hydrophobicity may be sufficient target for degradation.
Clarification of this issue remains to be elucidated.
Although the proteasome is responsible for degradation of
ubiquitinated proteins, it has also been shown that the
degradation of oxidized proteins can be carried out by the
20S proteasome in an ATP-independent manner and without
the presence of ubiquitin [53,56–78]. Indeed, experiments
conducted on erythrocytes or reticulocytes, using intact cells
and extracts, show that ATP is not necessary for the degradation
of oxidized proteins and that ATP may even induce a partial
inhibition of the reaction [79–81]. Nevertheless there are other
studies which report involvement of the ubiquitin system in this
process. They demonstrate that both the ATP-independent and
ATP/ubiquitin-dependent proteolytic pathways are responsible
for the degradation of native and oxidized α-crystallin in
bovine lens epithelial cells [82,83]. Thus, some controversy
still exits within the literature as to whether the proteasome may
operate in an ATP-independent as well as an ATP-dependent
manner.
As described previously, mildly oxidized proteins may
undergo several alterations which increase their susceptibility
to proteolysis. One of the most important changes is the
rearrangement of their secondary and tertiary structure. This
unfolding process induces them to expose hydrophobic
residues otherwise hidden in the normal conformation. It has
been shown that the exposure of these hydrophobic residues
allows the proteasome to recognize and bind its substrates, and
start the degradation process [53,56–73]. The result of
proteasome activity is the production of short peptides which
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function of these peptidases is poorly understood, and deserves
further attention.
The proteasome is not the only cellular structure able to
degrade oxidized proteins. The lysosomal system contains
different proteases which can contribute to protein turnover.
Lysosome-mediated proteolysis is mainly non-selective and has
as substrates long-lived proteins. These enzymes are able to
process both extracellular and intracellular substrates thanks to
two different mechanisms: autophagy and endocytosis.
Through autophagy lysosomes can degrade intracellular
components. There are three different types of autophagy
including macroautophagy, microautophagy and chaperone-
mediated autophagy (CMA) [84,85]. Macroautophagy is
activated upon multiple stimuli including starvation, and allows
cells to recycle cellular components in order to maintain cellular
homeostasis. Organelles, such as mitochondria or peroxisomes,
and entire regions of cytosol are internalized in an intracellular
double membrane, probably originated from endoplasmic
reticulum [84,85]. This structure, named an autophagosome,
then fuses with lysosomes which facilitate the degradation of
those protein present [84,85]. In contrast, microautophagy is a
continuous process and occurs under normal nutritional
conditions. In this case it is the lysosomal membrane which is
responsible for the sequestration of cytosol regions. Once the
target cytosolic region is sequestered and the outer membrane
disrupted, the trapped proteins are then degraded by lysosomal
enzymes. The third lysosomal mechanism of degradation is
called CMA and is mainly activated upon oxidative stress. This
process acts in a selective way since it is specific for substrates
carrying a KFERQ motif. This motif is recognized by an
intracellular chaperone, the heat shock cognate protein of
73 kDa (hsc73), which guides it to the lysosome. Once at the
lysosome, hsc73 interacts with its receptor, the lysosomal
membrane protein (LAMP-2A) and allows the targeted protein
to interact with a second lysosome-specific chaperone, hsc73
(lys-hsc73). This chaperone then helps the target protein to be
translocated into the lysosomal lumen and subsequently
degraded [84–86]. Recent studies indicate lysosomes and
autophagy contribute to oxidized protein degradation [85],
although the significance of this contribution remains to be
elucidated.
Oxidative stress can contribute to cellular dysfunction by
directly damaging the lysosomal membrane. This leads to the
release of the lysosomal enzymes into the cytosol with serious
consequences for cytosolic components and an increased risk in
cell death. Nevertheless, there is also evidence for a protective
role of lysosomes during stressful periods. They can contribute
to the elimination of oxidized and damaged proteins, especially
through the chaperone-mediated autophagy pathway. Studies on
cultured mouse fibroblasts and rat liver show that in conditions
of mild oxidation there is a constitutive activation of CMAwith
an increased degradation of its substrates [86]. Furthermore,
there is a more efficient binding and translocation of oxidized
proteins to the lysosome, with a concomitant increase in the
synthesis of lysosome-associated chaperones and of the
membrane receptor LAMP-2A [86].Removal of oxidized proteins is crucial for cell survival.
Indeed, if oxidized proteins are not eliminated either through
proteasomal or lysosomal pathways, they are able to begin to
accumulate and potentially aggregate. These aggregates can
alter cell functions and lead to necrosis or apoptosis.
Furthermore, these aggregates are extremely resistant to
proteolysis and can act as inhibitory compounds towards both
the proteasome and lysosome degradation pathways [52,53].
For example, lysosome hydrolase activity has been shown to be
impaired by protein aggregates resulting from prolonged
exposure to free radicals. Furthermore, treatment of mouse
peritoneal macrophages with oxidized low density lipoprotein
induces a decrease in the degradation activity of the lysosomal
enzyme, cathepsin B [87]. Exposure of murine macrophage-like
cells to protein hydroperoxides inhibits cathepsin L and B in a
time- and dose-dependent manner [88]. All of these findings
implicate oxidative stress as a contributing factor in the
impairment of proteolytic systems responsible for the removal
of oxidized and damaged macromolecules. This impairment, in
turn, induces an increase in the cytoplasmic levels of oxidized
proteins, leading to further elevations in protein oxidation.
Oxidatively modified proteins that are not completely removed
can potentially interact with other cellular components like
lipids, carbohydrates and metals giving rise to an autofluor-
escent, brown-yellow pigment, termed lipofuscin [89,90].
Lipofuscin is mainly generated in the lysosomal compartment.
It has been shown that lipofuscin production is increased by the
presence of H2O2 derived from the mitochondrial respiration.
Iron originating from the degradation of metalloproteins may
also contribute to lipofuscin production. Once lipofuscin begins
to accumulate, it may reduce lysosomal activity, thus increasing
cellular susceptibility to oxidative stress. Interestingly, much
like protein aggregates, lipofuscin is highly resistant to
proteolysis and is considered a hallmark of aging [89,90].
Interestingly, recent studies indicate that proteasome inhibition
is sufficient to increase lipofuscin, with elevations in lipofuscin
were associated with a decline in mitochondrial respiration.
This is in line with additional studies demonstrating that
proteasome inhibitors have deleterious effects on mitochondrial
homeostasis. These findings provide further linkages between
proteolysis, protein oxidation, and metabolism.
5. Protein oxidation and cellular dysfunction
The reactions of glycolysis involve a variety of enzymes,
including hexose kinase, phosphoglucose isomerase, phospho-
fructokinase, aldolase, gluceradlehdye-3-phosophate dehydro-
genase (GAPDH), phosphoglycerate kinase, phosphoglycerate
mutase, enolase, and pyruvate kinase. The byproducts of these
enzymatic reactions are ATP, NADH, and pyruvate which are
fed into the citric acid cycle for further production of ATP.
Numerous lines of investigation suggest that oxidation of
metabolic enzymes, such as those involved in glycolysis and the
citric acid cycle, may contribute to oxidative stress (Table 1).
The most-well studied enzyme of the glycolytic pathway is
GAPDH since it is one of the first enzymes capable of creating
a high-energy bond capable of ATP production. Inhibition of
Table 1
Effect of oxidative stressors on metabolic enzymes in various tissues
Enzyme altered by oxidant Type of oxidant Cell/tissue effected Change in enzymatic function Reference
GAPDH H2O2 Chondrocytes ↓ [93]
Lens epithelial cell line ↓ [94]
Myocardium ↓ [96,97,130]
Human red blood cells ↓ [95]
Acrylamide Extensor muscles ↓ [99]
Liver ↓
Peroneal and tibial nerve ↑ [100]
Schwann cells ↓
Sciatic nerve ↓ [99]
Aconitase Peroxynitrite Yeast ↓ [98]
Astrocytes ↓
Alpha-ketoglutarate dehydrogenase H2O2 Nerve terminal ↓ [108]
Cardiac mitochondria ↓ [110]
Succinate dehydrogenase H2O2 Nerve terminal ↓ [108]
Cardiac mitochondria ↓ [110]
3-nitropropionic acid Cerebellar neurons ↓ [112]
Cerebellar glia ↓
GABA neurons ↓ [111]
Murine Glia No Effect
Isocitrate dehydrogenase H2O2 Porcine Mitochondria ↓ [109]
Nerve terminal No Effect [108]
Cardiac mitochondria No Effect [110]
Potassium superoxide Porcine Mitochondria ↓ [109]
Cupric chloride Porcine Mitochondria ↓
Ascorbate Porcine Mitochondria ↓
Visible light Porcine Mitochondria ↓
Creatine kinase Peroxynitrite Mitochondria ↓ [121]
H2O2 Rat muscle ↓ [116]
Rat heart ↓
Rat brain ↓
Acrylamide Brain ↓ [125]
Plasma ↓
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which culminate in a loss of overall ATP production [91].
Many studies have identified an inhibition of GAPDH function
with increased amounts of hydrogen peroxide exposure. For
instance, isolated plant cells, chondrocytes, human red blood
cells, and a mouse lens epithelial cell line all display a
reduction of GAPDH following increasing concentrations of
H2O2 [92–95]. In vivo studies have also shown a reduction in
GAPDH activity in isolated rat myocardium, that implicate
H2O2
− mediated inhibition of GAPDH in vivo [96,97]. It is
interesting to note that the sensitivity of GAPDH to oxidative
inactivation may vary between cell types and vary in response
to specific oxidants. For example, GAPDH isolated from yeast
cells was found to be less sensitive to peroxynitrite oxidation
compared to GAPDH derived from rat astrocytes [98].
Similarly, acrylamide administration to rats more potently
inhibited GAPDH activity in the extensor muscles and liver
compared to the medulla, pons, cerebellum, and cortex [99].
Also, GAPDH activity was reported to increase in denervated
peroneal and tibial nerves of cats following acrylamide
exposure although the activity in Schwann cells was shown
to decrease [100]. GAPDH inhibition was also found to be
greater in primary rat neurons following H2O2 exposure as
compared to neurons exposed to diamide [101]. Finally,
acrylamide administered to rats was more potent in inducingGAPDH inhibition in sciatic and tibial nerves as compared to
glycidamide [102]. Together, these data indicate a cell type and
oxidant type specificity with regards to the ability of oxidants
to inhibit GADPH.
Inhibition of GAPDH via oxidative stress may also play a
vital role in modulation of cellular apoptosis and cell signaling,
independent of its effects on regulating ATP. GAPDH
expression has been reported to increase during apoptosis and
treatment of cells with anti-sense GAPDH was able to block
apoptosis completely [103]. More recent reports indicate that
GAPDH may translocate into the nucleus of stressed cells and
alter gene transcription related to cell survival [103]. Indeed,
following addition of H2O2 to neuroblastoma or embryo
fibroblast cell lines high amounts of GAPDH appeared
translocated into the nucleus [104]. An additional study has
shown that oxidized GAPDH may have enhanced binding
capabilities towards both tRNA and DNA [105]. GAPDH may
also promote apoptosis during oxidative stress via undergoing
self-aggregation and altering the functionality of other proteins
[98,101,103]. In contrast, other groups have suggested an anti-
apoptotic role for GAPDH under conditions of oxidative stress,
possibly due to GADPH binding to other proteins [106]. For
example, binding of GAPDH to phospholipase D2 in PC12
cells exposed to H2O2 regulates the activity of phospholipase
D2 and leads to a reduction in apoptosis [106]. Together, these
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expression of GADPH (via oxidation of GADPH) may be a
direct mechanism by which protein oxidation impinges upon
metabolism and viability.
Enzymes in the citric acid cycle may also be important for
cellular dysfunction caused by oxidative stress. Following
glycolysis, pyruvate is transported into the mitochondria via a
pyruvate-H+symportor. Pyruvate is then fed into the citric acid
cycle where it is acted upon by various enzymes including
pryuvate dehydrogenase, citrate synthase, aconitase, isocitrate
dehydrogenase, alpha ketoglutarate dehydrogenase, succinyl-
coa synthetase, succinate dehydrogenase, fumarase, and
malate dehydrogenase [107]. Under various oxidative condi-
tions, the activities of several of these enzymes have been
shown to be reduced, including alpha-ketoglutarate dehydro-
genase, isocitrate dehydrogenase, succinate dehydrogenase,
and aconitase [108–112]. The sensitivity of these enzymes to
oxidative stress, though, appears to be enzyme specific. For
example, in isolated nerve terminals citrate synthase, isocitrate
dehydrogenase, and malate dehydrogenase were unaffected by
H2O2 exposure although it induced a dramatic reduction in
aconitase, alpha-ketogluarate dehydrogenase, and succinate
dehydrogenase (Table 1). Interestingly, aconitase was shown
to be most sensitive to H2O2 in this paradigm [108]. Similar
results where obtained by exposure of isolated cardiac
mitochondria to H2O2 [110]. Unfortunately, due to differences
in the amount of H2O2 used in the different experimental
conditions it is difficult to determine whether nerve synapto-
somes or cardiac mitochondria are more sensitive to H2O2
exposure [108,110]. Similar to the effects of oxidative stress
on glycolysis, differences may occur in the inhibition of these
enzymes depending on the oxidative paradigm utilized. For
example, 3-NP was shown to inhibit succinate dehydrogenase
activity in cultured rat cerebellar neurons and astrocytes and
also murine GABA neurons but shown to have no effect on
succinate dehydrogenase activity in murine glia [111,112].
Also, isolated isocitrate dehydrogenase was shown to be
inhibited by H2O2 whereas other groups reported no effect
[109,113].
Another aspect of energy metabolism as it relates to
oxidative stress is the functionality of creatine kinase, the
enzyme which catalyzes the formation of phosphocreatine
which can rapidly generate ATP under conditions of high
energy demand. This enzyme is especially important in cell
types which require large amounts of ATP for their function,
including muscle and brain cells, and is not expressed in other
less energy demanding cell types such as hepatocytes [107].
Functional creatine kinase is a dimeric protein that can be
formed by two different types of monomers: M and B. The MM
form of creatine kinase resides mostly in muscle tissue whereas
the BB form is found mainly in the brain [107]. There is also a
MB isoform which resides in cardiac tissue. In addition, there
are intracellular pools of CK, one residing in the mitochondria
and the other in the cytosol [114]. Though the exact mechanism
underlying the inactivation of creatine kinase remains to
elucidated, most groups concur that the enzyme is highly
susceptible to H2O2 oxidation [113,115,116] and O2
− oxidation[117,118]. The active site of all isoforms of the creatine kinase
enzyme contain an essential sulfhydryl oxidation which may be
susceptible to oxidative modification [115,118]. Indeed, reduc-
tions in mitochondrial creatine kinase activity has been shown
to correlate with increases in protein sulfhydryl groups induced
by xanthine and xanthine oxidase [118]. Furthermore, treatment
of isolated CK with a variety of known oxidants, including
peroxynitrite, H2O2, S-nitroso-N-acetylcysteine, and S-nitroso-
glutathione, has shown inhibition of CK activity [119–121].
Also, oxidized CK regains activity following treatment with the
sulfhydryl reducing agent DTT. The inhibition of CK by
oxidants has also been reported in functional human kerotino-
cytes and rat monocytes and rat midbrain [120,122,123]. It
should be noted, however, that tissue-specific CK may display
differences in its response to oxidative stress. For example, CK
activities in the rat heart were reduced more so than in the
muscle or brain following treatment with xanthine and xanthine
oxidase [116]. However, this effect may be oxidant specific as
greater reduction of CK activity was seen in the brain compared
to muscle and heart following treatment with H2O2 [116]. Other
studies have also seen tissue-specific regulation of CK activity.
Wang et al. found a significant reduction in CK activity
following exposure to 1-bromopropane, with cerebrum and
brainstem specific-CK having greater inhibition than CK
located in the spinal cord or cerebellum [124]. Additionally,
CK inhibition by acrylamide was most significant in the brain of
mice but in rats was greatest in the plasma [125]. Finally, much
like the enzymes of glycolysis and the Krebs cycle, alteration of
CK may be oxidant specific. For example, glycidamide
inhibited CK in rats whereas acrylamide had no significant
effect [102]. Interestingly, aflatoxicosis and ochratoxin were
shown to actually increase CK activity in broiler chicks and
turkeys [7,8].
The inactivation of CK may have a variety of complica-
tions for cells, especially when energy demands are high. For
instance, isolated rat hearts were shown to maintain cardiac
performance when administered idoacetaminde, a CK inhib-
itor, under normal conditions, however, when energy demands
were high, CK inhibition decreased ventricular performance
and overall systolic function [126]. Similarly isolated muscle
cells have been shown to have reduced titanic peak tension
during exercise due to inhibition of muscle CK [127]. It is
also interesting to note that systolic and diastolic function
failed more rapidly in rat hearts undergoing CK inhibition,
indicating that disruption of CK function via oxidative stress
could lead to cardiac muscle failure [126]. CK inhibition may
also disrupt neuronal activity as CK activity has been shown
to correlate with neuronal firing [128,129]. There is some
evidence that inhibition of CK may underscore neuronal
damage incurred by toxins, leading to electrophysiological
alterations in peripheral nerve, axon swelling, and reductions
in cerebral volume [124].
6. Summary
It is clear that elevations in oxidative damage can promote
oxidative stress in a variety of cell types. The ability of oxidative
101V. Cecarini et al. / Biochimica et Biophysica Acta 1773 (2007) 93–104damage to induce cellular dysfunction is very dependent on its
ability to affect specific cellular processes, including metabolic
function. The ability of oxidants to promote dysfunction and
toxicity is cell type specific, which is likely mediated by the
ability of cells to successfully respond to oxidants by
removing, repairing, or replacing oxidized molecules. Thus
the ability of cells to respond favorably to oxidant exposure is
the ultimate predictor of whether a cell will exhibit oxidative
stress. Understanding the basis for this cell type specificity in
favorably responding to oxidant exposure is only beginning to
be understood, and represents one of the cutting edges of
oxidative stress research. The goal of such studies should be to
define why the amount of oxidative damage does not predict
the presence or severity of disease or dysfunction. Clearly, one
of the principle cellular targets of protein oxidation is cellular
metabolism. Oxidation of a limited number of metabolic
proteins can dramatically and deleteriously impact the overall
energy status of the cell, and thereby rapidly induce cellular
dysfunction through a limited number of protein oxidation
events. The ability of cells to prevent the oxidation of
metabolic proteins, or to repair or replace metabolic proteins
following oxidation, is likely to be an important predictor of
how well cells are able to successfully respond to oxidative
stressors. Studies which are designed to explore this important
aspect of protein oxidation research in a cell type specific
manner will likely yield data that is important in aging,
diabetes, cancer, cardiovascular, and neuroscience research
[131].
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